HIF1A and Alzheimer disease: Enhanced expression of HIF-1α in Aβ plaque-associated microglia has been confirmed in various in vivo AD models, and activation of HIF-1α signaling has been proposed as a detrimental modulator of AD pathology, as enhanced or inhibited HIF-1α signaling occurred concurrently with enhanced or attenuated Aβ deposition [32].